Antwort

Literatur
1 Kratzsch J, Petzold A, Raue F. et al. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem 2011; 57: 467-474 . doi:10.1373/clinchem.2010.151688
2 Kahaly GJ, Algeciras-Schimnich A, Davis TE. et al. United States and European Multicenter Prospective Study for the Analytical Performance and Clinical Validation of a Novel Sensitive Fully Automated Immunoassay for Calcitonin. Clin Chem 2017; 63: 1489-1496 . doi:10.1373/clinchem.2016.270009
3 Alves TG, Kasamatsu TS, Yang JH. et al. Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay. J Clin Endocrinol Metab 2016; 101: 653-658 . doi:10.1210/jc.2015-3137
4 Fangous MS, Kerspern H, Moineau MP. et al. The hook effect in calcitonin immunoradiometric assay: a case report. Ann Endocrinol (Paris) 2012; 73: 552-555 . doi:10.1016/j.ando.2012.07.681
5 Leboeuf R, Langlois MF, Martin M. et al. “Hook effect” in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature. J Clin Endocrinol Metab 2006; 91: 361-364 . doi:10.1210/jc.2005-1429
6 Censi S, Cavedon E, Fernando SW. et al. Calcitonin measurement and immunoassay interference: a case report and literature review. Clin Chem Lab Med 2016; 54: 1861-1870 . doi:10.1515/cclm-2015-1161
7 Papapetrou PD, Polymeris A, Karga H. et al. Heterophilic antibodies causing falsely high serum calcitonin values. J Endocrinol Invest 2006; 29: 919-923 . doi:10.1007/BF03349197
8 Giovanella L, Giordani I, Imperiali M. et al. Measuring procalcitonin to overcome heterophilic-antibody-induced spurious hypercalcitoninemia. Clin Chem Lab Med 2018; 56: e191-e193 . doi:10.1515/cclm-2017-0993